IA
AKTS

IFP Advisors’s Aktis Oncology AKTS Stock Holding History

IFP Advisors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25K Buy
+101
New +$2.07K ﹤0.01% 4016

Other funds holding AKTS

MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

IFP Advisors's AKTS Position: Q2 2026 in Review

IFP Advisors opened a new position in Aktis Oncology (AKTS) in Q2 2026: 101 shares worth $3.25K. The stake represents ﹤0.01% of the portfolio and ranks #4016 among its holdings.

8 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • IFP Advisors held 101 shares of Aktis Oncology worth $3.25K as of Q2 2026.
  • Aktis Oncology was a new IFP Advisors position in Q2 2026.
  • Aktis Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4016 holding.
  • 8 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.